The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia

Journal of Immunology

Volumn 182, Issue 7, 2009, Pages 4349-4356

  Van Zoelen, Marieke A D ^a   Schouten, Marcel ^a   De Vos, Alex F ^a   Florquin, Sandrine ^a   Meijers, Joost C M ^a   Nawroth, Peter P ^b   Bierhaus, Angelika ^b   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; CHEMOKINE; IMMUNOGLOBULIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; HISTOPATHOLOGY; HOST RESISTANCE; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; LUNG LAVAGE; MICROBIOLOGY; MOUSE MUTANT; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PATHOLOGY;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; PNEUMONIA, PNEUMOCOCCAL; RECEPTORS, IMMUNOLOGIC; STREPTOCOCCUS PNEUMONIAE;

EID: 64249138285     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0801199     Document Type: Article

References (60)

1. Niederman, M. S., L. A. Mandell, A. Anzueto, J. B. Bass, W. A. Broughton, G. D. Campbell, N. Dean, T. File, M. J. Fine, P. A. Gross, et al. 2001. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am. J. Respir. Crit. Care Med. 163: 1730-1754.
2. Bartlett, J. G., S. F. Dowell, L. A. Mandell, T. M. File Jr., D. M. Musher, and M. J. Fine. 2000. Practice guidelines for the management of community-acquired pneumonia in adults: Infectious Diseases Society of America. Clin. Infect. Dis. 31: 347-382.
3. Campbell, G. D., Jr., and R. Silberman. 1998. Drug-resistant Streptococcus pneumoniae. Clin. Infect. Dis. 26: 1188-1195.
4. Kislinger, T., C. Fu, B. Huber, W. Qu, A. Taguchi, Y. S. Du, M. Hofmann, S. F. Yan, M. Pischetsrieder, D. Stern, and A. M. Schmidt. 1999. N(ε)-(carboxymethyl) lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J. Biol. Chem. 274: 31740-31749. (Pubitemid 129501639)
5. Yan, S. D., H. Zhu, A. Zhu, A. Golabek, H. Du, A. Roher, J. Yu, C. Soto, A. M. Schmidt, D. Stern, and M. Kindy. 2000. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat. Med. 6: 643-651.
6. Yan, S. D., X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, et al. 1996. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691. (Pubitemid 26282167)
7. Sorci, G., F. Riuzzi, C. Arcuri, I. Giambanco, and R. Donato. 2004. Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding. Mol. Cell. Biol. 24: 4880-4894. (Pubitemid 38668053)
8. Hori, O., J. Brett, T. Slattery, R. Cao, J. Zhang, J. X. Chen, M. Nagashima, E. R. Lundh, S. Vija, and D. Nitecki. 1995. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270: 25752-25761.
9. Moroz, O. V., A. A. Antson, E. J. Dodson, H. J. Burrell, S. J. Grist, R. M. Lloyd, N. J. Maitland, G. G. Dodson, K. S. Wilson, E. Lukanidin, and I. B. Bronstein. 2002. The structure of S100A12 in a hexameric form and its proposed role in receptor signalling. Acta Crystallogr. D Biol. Crystallogr. 58: 407-413.
10. Valencia, J. V., M. Mone, J. Zhang, M. Weetall, F. P. Buxton, and T. E. Hughes. 2004. Divergent pathways of gene expression are activated by the RAGE ligands S100b and AGE-BSA. Diabetes 53: 743-751.
11. Arumugam, T., D. M. Simeone, A. M. Schmidt, and C. D. Logsdon. 2004. S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J. Biol. Chem. 279: 5059-5065. (Pubitemid 38220521)
12. Schmidt, A. M., M. Vianna, M. Gerlach, J. Brett, J. Ryan, J. Kao, C. Esposito, H. Hegarty, W. Hurley, and M. Clauss. 1992. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. Biol. Chem. 267: 14987-14997.
13. Neeper, M., A. M. Schmidt, J. Brett, S. D. Yan, F. Wang, Y. C. Pan, K. Elliston, D. Stern, and A. Shaw. 1992. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267: 14998-15004.
14. Cheng, C., K. Tsuneyama, R. Kominami, H. Shinohara, S. Sakurai, H. Yonekura, T. Watanabe, Y. Takano, H. Yamamoto, and Y. Yamamoto. 2005. Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs. Mod. Pathol. 18: 1385-1396. (Pubitemid 41348659)
15. Englert, J. M., L. E. Hanford, N. Kaminski, J. M. Tobolewski, R. J. Tan, C. L. Fattman, L. Ramsgaard, T. J. Richards, I. Loutaev, P. P. Nawroth, et al. 2008. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am. J. Pathol. 172: 583-591. (Pubitemid 351354532)
16. Morbini, P., C. Villa, I. Campo, M. Zorzetto, S. Inghilleri, and M. Luisetti. 2006. The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Mod. Pathol. 19: 1437-1445. (Pubitemid 44624162)
17. Uchida, T., M. Shirasawa, L. B. Ware, K. Kojima, Y. Hata, K. Makita, G. Mednick, Z. A. Matthay, and M. A. Matthay. 2006. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am. J. Respir. Crit. Care Med. 173: 1008-1015.
18. Wittkowski, H., A. Sturrock, M. A. van Zoelen, D. Viemann, T. van der Poll, J. R. Hoidal, J. Roth, and D. Foell. 2007. Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome. Crit. Care Med. 35: 1369-1375. (Pubitemid 46642668)
19. Cataldegirmen, G., S. Zeng, N. Feirt, N. Ippagunta, H. Dun, W. Qu, Y. Lu, L. L. Rong, M. A. Hofmann, T. Kislinger, et al. 2005. RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-α and NF-κB. J. Exp. Med. 201: 473-484. (Pubitemid 40229421)
20. Zeng, S., N. Feirt, M. Goldstein, J. Guarrera, N. Ippagunta, U. Ekong, H. Dun, Y. Lu, W. Qu, A. M. Schmidt, and J. C. Emond. 2004. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice. Hepatology 39: 422-432. (Pubitemid 38222183)
21. Ekong, U., S. Zeng, H. Dun, N. Feirt, J. Guo, N. Ippagunta, J. V. Guarrera, Y. Lu, A. Weinberg, W. Qu, et al. 2006. Blockade of the receptor for advanced glycation end products attenuates acetaminophen-induced hepatotoxicity in mice. J. Gastroenterol. Hepatol. 21: 682-688.
22. Park, L., K. G. Raman, K. J. Lee, Y. Lu, L. J. Ferran Jr., W. S. Chow, D. Stern, and A. M. Schmidt. 1998. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat. Med. 4: 1025-1031. (Pubitemid 28417334)
23. Goova, M. T., J. Li, T. Kislinger, W. Qu, Y. Lu, L. G. Bucciarelli, S. Nowygrod, B. M. Wolf, X. Caliste, S. F. Yan, et al. 2001. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am. J. Pathol. 159: 513-525.
24. Liliensiek, B., M. A. Weigand, A. Bierhaus, W. Nicklas, M. Kasper, S. Hofer, J. Plachky, H. J. Grone, F. C. Kurschus, A. M. Schmidt, et al. 2004. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J. Clin. Invest. 113: 1641-1650. (Pubitemid 39071688)
25. Hofmann, M. A., S. Drury, B. I. Hudson, M. R. Gleason, W. Qu, Y. Lu, E. Lalla, S. Chitnis, J. Monteiro, M. H. Stickland, et al. 2002. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun. 3: 123-135.
26. Knapp, S., C. W. Wieland, C. van't Veer, O. Takeuchi, S. Akira, S. Florquin, and T. van der Poll. 2004. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J. Immunol. 172: 3132-3138.
27. Dessing, M. C., S. Knapp, S. Florquin, A. F. de Vos, and T. van der Poll. 2007. CD14 facilitates invasive respiratory tract infection by Streptococcus pneumoniae. Am. J. Respir. Crit. Care Med. 175: 604-611.
28. Rijneveld, A. W., S. Florquin, J. Branger, P. Speelman, S. J. van Deventer, and T. van der Poll. 2001. TNF-α compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia. J. Immunol. 167: 5240-5246.
29. Leemans, J. C., M. J. Vervoordeldonk, S. Florquin, K. P. van Kessel, and T. van der Poll. 2002. Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus. Am. J. Respir. Crit. Care Med. 165: 1445-1450.
30. Rijneveld, A. W., S. Weijer, S. Florquin, C. T. Esmon, J. C. Meijers, P. Speelman, P. H. Reitsma, H. Ten Cate, and T. van der Poll. 2004. Thrombo-modulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide. Blood 103: 1702-1709.
31. Weijer, S., S. H. Schoenmakers, S. Florquin, M. Levi, G. P. Vlasuk, W. E. Rote, P. H. Reitsma, C. A. Spek, and T. van der Poll. 2004. Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in mice. J. Infect. Dis. 189: 2308-2317. (Pubitemid 38757205)
32. Knapp, S., U. Matt, N. Leitinger, and T. van der Poll. 2007. Oxidized phospholipids inhibit phagocytosis and impair outcome in Gram-negative sepsis in vivo. J. Immunol. 178: 993-1001. (Pubitemid 46095173)
33. Blander, J. M., and R. Medzhitov. 2004. Regulation of phagosome maturation by signals from Toll-like receptors. Science 304: 1014-1018.
34. Orlova, V. V., E. Y. Choi, C. Xie, E. Chavakis, A. Bierhaus, E. Ihanus, C. M. Ballantyne, C. G. Gahmberg, M. E. Bianchi, P. P. Nawroth, and T. Chavakis. 2007. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J. 26: 1129-1139. (Pubitemid 46303578)
35. Zen, K., C. X. Chen, Y. T. Chen, R. Wilton, and Y. Liu. 2007. Receptor for advanced glycation endproducts mediates neutrophil migration across intestinal epithelium. J. Immunol. 178: 2483-2490. (Pubitemid 46233449)
36. Chavakis, T., A. Bierhaus, N. Al Fakhri, D. Schneider, S. Witte, T. Linn, M. Nagashima, J. Morser, B. Arnold, K. T. Preissner, and P. P. Nawroth. 2003. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J. Exp. Med. 198: 1507-1515. (Pubitemid 37467165)
37. Zhang, P., W. R. Summer, G. J. Bagby, and S. Nelson. 2000. Innate immunity and pulmonary host defense. Immunol. Rev. 173: 39-51. (Pubitemid 30095209)
38. Knapp, S., M. J. Schultz, and T. van der Poll. 2005. Pneumonia models and innate immunity to respiratory bacterial pathogens. Shock 24(Suppl. 1): 12-18. (Pubitemid 43756013)
39. Moore, T. A., and T. J. Standiford. 2001. Cytokine immunotherapy during bacterial pneumonia: from benchtop to bedside. Semin. Respir. Infect. 16: 27-37.
40. Gunther, A., P. Mosavi, S. Heinemann, C. Ruppert, H. Muth, P. Markart, F. Grimminger, D. Walmrath, B. Temmesfeld-Wollbruck, and W. Seeger. 2000. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia: comparison with the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 161: 454-462. (Pubitemid 30129452)
41. Schultz, M. J., J. J. Haitsma, H. Zhang, and A. S. Slutsky. 2006. Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia: a review. Crit. Care Med. 34: 871-877. (Pubitemid 43308283)
42. He, M., H. Kubo, K. Ishizawa, A. E. Hegab, Y. Yamamoto, H. Yamamoto, and M. Yamaya. 2007. The role of the receptor for advanced glycation end-products in lung fibrosis. Am. J. Physiol. 293: L1427-L1436. (Pubitemid 350255025)
43. Huttunen, H. J., C. Fages, and H. Rauvala. 1999. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274: 19919-19924. (Pubitemid 129519445)
44. Bierhaus, A., S. Schiekofer, M. Schwaninger, M. Andrassy, P. M. Humpert, J. Chen, M. Hong, T. Luther, T. Henle, I. Kloting, et al. 2001. Diabetes-associated sustained activation of the transcription factor nuclear factor-κB. Diabetes 50: 2792-2808. (Pubitemid 33733131)
45. Chavakis, T., A. Bierhaus, and P. P. Nawroth. 2004. RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes Infect. 6: 1219-1225. (Pubitemid 39370091)
46. Van Zoelen, M. A., P. F. Laterre, S. Q. van Veen, J. W. van Till, X. Wittebole, P. Bresser, M. W. Tanck, T. Dugernier, A. Ishizaka, M. A. Boermeester, and T. van der Poll. 2007. Systemic and local high mobility group box 1 concentrations during severe infection. Crit. Care Med. 35: 2799-2804. (Pubitemid 350175778)
47. Fuellen, G., D. Foell, W. Nacken, C. Sorg, and C. Kerkhoff. 2003. Absence of S100A12 in mouse: implications for RAGE-S100A12 interaction. Trends Immunol. 24: 622-624. (Pubitemid 37485909)
48. Laterre, P. F., X. Wittebole, and J. F. Dhainaut. 2003. Anticoagulant therapy in acute lung injury. Crit. Care Med. 31: S329-S336. (Pubitemid 36458188)
49. Cai, H., C. Song, I. Endoh, J. Goyette, W. Jessup, S. B. Freedman, H. P. McNeil, and C. L. Geczy. 2007. Serum amyloid A induces monocyte tissue factor. J. Immunol. 178: 1852-1860. (Pubitemid 46154658)
50. Bierhaus, A., T. Illmer, M. Kasper, T. Luther, P. Quehenberger, H. Tritschler, P. Wahl, R. Ziegler, M. Muller, and P. P. Nawroth. 1997. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation 96: 2262-2271. (Pubitemid 27425832)
51. Kislinger, T., N. Tanji, T. Wendt, W. Qu, Y. Lu, L. J. Ferran Jr., A. Taguchi, K. Olson, L. Bucciarelli, M. Goova, et al. 2001. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Arterioscler. Thromb. Vasc. Biol. 21: 905-910. (Pubitemid 34168644)
52. Levi, M., P. T. van der, and H. R. Buller. 2004. Bidirectional relation between inflammation and coagulation. Circulation 109: 2698-2704.
53. Rijneveld, A. W., S. Weijer, P. Bresser, S. Florquin, G. P. Vlasuk, W. E. Rote, C. A. Spek, P. H. Reitsma, J. S. van der Zee, M. Levi, and T. van der Poll. 2006. Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia. Crit. Care Med. 34: 1725-1730.
54. Lutterloh, E. C., S. M. Opal, D. D. Pittman, J. C. Keith Jr., X. Y. Tan, B. M. Clancy, H. Palmer, K. Milarski, Y. Sun, J. E. Palardy, et al. 2007. Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection. Crit. Care 11: R122.
55. Jones, M. R., B. T. Simms, M. M. Lupa, M. S. Kogan, and J. P. Mizgerd. 2005. Lung NF-κB activation and neutrophil recruitment require IL-1 and TNF receptor signaling during pneumococcal pneumonia. J. Immunol. 175: 7530-7535.
56. Mizgerd, J. P. 2008. Acute lower respiratory tract infection. N. Engl. J. Med. 358: 716-727.
57. Van der Poll, T., C. V. Keogh, W. A. Buurman, and S. F. Lowry. 1997. Passive immunization against tumor necrosis factor-α impairs host defense during pneumococcal pneumonia in mice. Am. J. Respir. Crit. Care Med. 155: 603-608.
58. Kirby, A. C., J. G. Raynes, and P. M. Kaye. 2005. The role played by tumor necrosis factor during localized and systemic infection with Streptococcus pneumoniae. J. Infect. Dis. 191: 1538-1547.
59. Sun, K., S. L. Salmon, S. A. Lotz, and D. W. Metzger. 2007. Interleukin-12 promotes γ interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection. Infect. Immun. 75: 1196-1202. (Pubitemid 46385810)
60. Quinton, L. J., M. R. Jones, B. T. Simms, M. S. Kogan, B. E. Robson, S. J. Skerrett, and J. P. Mizgerd. 2007. Functions and regulation of NF-κB RelA during pneumococcal pneumonia. J. Immunol. 178: 1896-1903.